OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

November 1, 2025

Study Completion Date

October 1, 2027

Conditions
Pancreatic NeoplasmDigestive System NeoplasmNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmDigestive System DiseasePancreatic DiseasesEndocrine System Diseases
Trial Locations (9)

28034

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

28942

RECRUITING

Hospital Universitario de Fuenlabrada, Madrid

Unknown

RECRUITING

Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria

NOT_YET_RECRUITING

Hospital Universitario Doce De Octobre, Madrid

NOT_YET_RECRUITING

Hospital Universitario La Paz, Madrid

RECRUITING

Clinica Universidad De Navarra, Pamplona

RECRUITING

Hospital Clinico Universitario De Valladolid, Valladolid

NOT_YET_RECRUITING

Hammersmith Hospital, London

NOT_YET_RECRUITING

The London Clinic, London

Sponsors
All Listed Sponsors
lead

OncoSil Medical Limited

INDUSTRY

NCT04493632 - OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. | Biotech Hunter | Biotech Hunter